A viral outbreak in China sounds alarmingly familiar to 2019, back in the days before most of us had ever heard of the ...

Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

It started as a respiratory illness – or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that causes COVID-19, was so much more.

Here’s what to know about the United States’ first confirmed severe case of H5N1 avian influenza—and how to protect yourself.

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

the context of an acute severe acute respiratory syndrome coronavirus 2 infection. The researchers found that some of those ...

severe pneumonia, acute respiratory distress syndrome in few which require hospitalization, oxygen therapy including ...

Analysis included two control groups: Strict control group (LRTD events negative for RSV, human metapneumovirus, severe acute respiratory syndrome coronavirus 2, and influenza but positive for ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...